What's Happening?
Myriad Genetics, a molecular diagnostic testing company based in Salt Lake City, has partnered with Amazon Web Services (AWS) to enhance its artificial intelligence capabilities for document processing. The company processes approximately 1.5 million
diagnostic tests annually, which involves complex revenue cycle management tasks such as insurance claims and reimbursement operations. Initially, Myriad developed an AI tool internally to automate these processes, but high costs led them to collaborate with AWS. The new AI system, Image Genius, has significantly reduced document processing time from 10 minutes to 20 seconds per document. This improvement is crucial for accelerating repayment cycles and ensuring timely insurance coverage for patients. The tool, which uses AWS's machine learning services, is expected to expand to Myriad's oncology and mental health units by 2027.
Why It's Important?
The collaboration between Myriad Genetics and AWS highlights the growing importance of AI in healthcare, particularly in streamlining administrative processes. By reducing the time and cost associated with document processing, Myriad can improve its operational efficiency and financial performance. This development is significant for the healthcare industry, as it demonstrates how AI can address challenges in revenue cycle management, potentially leading to faster patient care and reduced administrative burdens. The success of this initiative could encourage other healthcare organizations to adopt similar technologies, driving further innovation and efficiency in the sector.
What's Next?
Myriad Genetics plans to continue expanding the use of AI across its operations, with a focus on automating various aspects of the revenue cycle, including eligibility verification and claims submission. The company aims to roll out the Image Genius tool to additional business units, such as oncology and mental health, by 2027. This expansion will likely involve further collaboration with AWS to refine and optimize the AI models used. As Myriad continues to enhance its AI capabilities, it may face challenges related to data privacy and security, which will require careful management to maintain trust with patients and partners.
